2022 Webinars


Reducing the risk of Plasmodium vivax after P. falciparum infections in co-endemic areas – a randomized controlled trial

Associate Professor Kamala Ley-Thriemer, Principal Research Fellow, Menzies School of Health Research


Image courtesy of Pearl Gan

Exploring malaria parasite transmission and drug resistance in Cambodia using population genetics and Defining the fine specificity of antibody responses to polymorphic and conserved epitopes of the lead malaria vaccine antigen: Plasmodium falciparum cirumsporozoite protein

Dr Kirsty McCann, Research Fellow, Genomic Epidemiology, Deakin University
Alessia Hysa, Masters Student, Burnet Institute



Understanding patterns of antigen diversity and immune selection pressure amongst leading Plasmodium vivax vaccine candidates and serosurveillance markers 

Paolo Bareng, PhD Student, IMPACT, Deakin University and CIIDIR



Evaluation of a pharmacokinetic-pharmacodynamic model for predicting parasitological outcomes in Phase 2 studies of new antimalarial drugs

Professor Julie Simpson, Professor & Director Of Health Clinical Research Melbourne School of Population and Global Health, University of Melbourne
Dr Angela Devine, Senior Research Fellow and Lecturer in Public Health, Menzies School of Health Research


Image courtesy of Pearl Gan

Direct Membrane Feeding Assay and Direct Skin Feeding Assay in Papua New Guinea and Anti-gametocyte antibodies and gametocytemia in patients with clinical falciparum malaria: A multinational study

Mr Lincoln Timinao, Scientific Officer, Papua New Guinea Institute of Medical Research
Dr Katherine O’Flaherty, Postdoctoral Scientist, Burnet Institute